- Report
- October 2021
- 248 Pages
Global
From €4362EUR$4,950USD£3,758GBP
- Report
- June 2023
- 289 Pages
Global
From €4746EUR$5,574USD£3,950GBP
- Report
- May 2021
- 177 Pages
United States
€1317EUR$1,495USD£1,135GBP
- Report
- July 2024
- 102 Pages
Global
From €1498EUR$1,700USD£1,290GBP
- Report
- June 2024
- 51 Pages
China
From €969EUR$1,100USD£835GBP
- Report
- March 2024
- 66 Pages
Global
From €1101EUR$1,250USD£949GBP
- Report
- October 2023
- 157 Pages
Global
From €3965EUR$4,500USD£3,416GBP
- Report
- October 2023
- 159 Pages
Global
From €3965EUR$4,500USD£3,416GBP
- Report
- September 2023
- 135 Pages
Global
From €3965EUR$4,500USD£3,416GBP
- Report
- January 2024
Global
From €4274EUR$4,850USD£3,682GBP
- Report
- July 2023
- 281 Pages
Global
From €3701EUR$4,200USD£3,188GBP
- Report
- February 2022
- 134 Pages
Global
From €2996EUR$3,400USD£2,581GBP
- Report
- January 2022
- 133 Pages
Global
From €2996EUR$3,400USD£2,581GBP
- Report
- April 2023
- 75 Pages
Global
From €3304EUR$3,750USD£2,847GBP
- Report
- July 2024
- 226 Pages
Global
From €2194EUR$2,490USD£1,890GBP
- Report
- April 2024
- 159 Pages
Global
From €1842EUR$2,090USD£1,587GBP
- Report
- June 2023
- 720 Pages
Global
From €3701EUR$4,200USD£3,188GBP
- Report
- April 2018
- 100 Pages
India
From €1586EUR$1,800USD£1,366GBP
- Report
- March 2018
- 100 Pages
United States
From €2115EUR$2,400USD£1,822GBP
- Report
- April 2018
- 97 Pages
Global
From €14099EUR$16,000USD£12,146GBP

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more